| |
|
|
|
Matinas BioPharma Holdings Inc.  
|
|
1.04 -0.01 (-0.01%) |
02-19 16:00 |
|
Open: |
1.05 |
Pre close: |
1.05 |
Target:
|
1.40
|
|
High: |
1.0704 |
Low: |
1.04 |
Resistance:
|
1.20
1.40
|
|
Volume: |
351,442 |
Market Cap: |
117M |
Support:
|
1.00
0.88
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.05
 |
MACD |
MACD(12,26):
|
0.05 |
|
MA(20): |
1.03 |
Signal(12,26,9): |
0.06 |
|
MA(100): |
0.84  |
Stochastic Oscillator |
%K(14,3):
|
56.77 |
|
MA(250): |
0.69 |
%D(3): |
59.04 |
|
Average Volume(K) |
3-Month: |
92999
|
52-Week |
High:
|
1.48 |
|
10-Days: |
61350 |
Low: |
0.32 |
|
RSI |
RSI(14):
|
55.16 |
Change(%): |
4.0 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-531.5 |
Shares Out. (M) |
112.39 |
|
EPS Est. Current Year |
-0.290 |
Return on Assets (ttm) |
-96.7 |
Shares Float (M) |
99.10 |
|
EPS Est. Next Year |
-0.240 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.050 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
10.10 |
|
Forward EPS |
-0.140 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
5722 |
|
Book Value (p.s.) |
11.750 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.09 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-9.62 |
P/S |
0.00 |
|
Operating Margin |
-8934.08 |
Levered Free Cash Flow
(M) |
-4.54 |
P/CF |
-12.15 |
|
|
|
|
|
|
